MedTrace Logo

Effects of Auricular Acupressure and Group Counseling on Smoking Cessation Tobacco Withdrawal Symptoms

NCT02916628 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2021-02-10

No results posted yet for this study

Summary

Objective The purpose of this study is to examine the effects of auricular acupressure and group counseling with positive psychology and motivational interviewing on smoking cessation and tobacco withdrawal symptoms.

Methods This study is a single blind randomized controlled trial. This study has been performed at a University in South Korea. 180 smokers and 60 non-smokers will be recruited. Smokers will be randomly assigned to three groups: group 1 (auricular acupressure + group counseling); group 2 (placebo acupressure + group counseling); and the control group (self-help smoking cessation). Group counseling is undertaken once per week for 6 weeks. Auricular acupressure using acupellets is performed for 6 weeks continuously.

Conditions

  • Smoking

Interventions

BEHAVIORAL

group counseling

Group counseling with positive psychology and motivational interviewing was undertaken once per week for 6 weeks.

DEVICE

Auricular acupressure

Auricular acupressure using acupellets was performed for 6 weeks continuously

DEVICE

placebo acupressure

Placebo acupellets were prepared without metal projections, and placed on both sides in the same areas of the ear as the active condition.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-02-28
Completion
2019-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02916628 on ClinicalTrials.gov